Nukkleus (NASDAQ:DFNS) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of Nukkleus (NASDAQ:DFNS) to a sell rating in a report released on Saturday.

Other research analysts have also issued research reports about the stock. Weiss Ratings lowered shares of Nukkleus from a “sell (d+)” rating to a “sell (e+)” rating in a report on Monday, July 20th. Noble Financial raised shares of Nukkleus to a “strong-buy” rating in a report on Monday, June 29th. One investment analyst has rated the stock with a Strong Buy rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy”.

Nukkleus Price Performance

Shares of DFNS opened at $13.10 on Friday. The company has a quick ratio of 0.21, a current ratio of 0.25 and a debt-to-equity ratio of 0.07. The stock has a market cap of $9.96 million, a PE ratio of -4.46 and a beta of -5.82. Nukkleus has a 12-month low of $3.70 and a 12-month high of $1,948.75. The business has a 50-day simple moving average of $26.39 and a two-hundred day simple moving average of $136.61.

Nukkleus (NASDAQ:DFNS) last announced its quarterly earnings results on Wednesday, May 20th. The company reported ($142.50) EPS for the quarter. The firm had revenue of $3.65 million during the quarter. Analysts anticipate that Nukkleus will post -63.98 earnings per share for the current fiscal year.

Institutional Trading of Nukkleus

Several institutional investors have recently added to or reduced their stakes in DFNS. BNP Paribas Financial Markets acquired a new stake in Nukkleus during the 2nd quarter valued at approximately $56,000. State Street Corp lifted its position in shares of Nukkleus by 70.7% in the 4th quarter. State Street Corp now owns 17,863 shares of the company’s stock worth $72,000 after purchasing an additional 7,400 shares during the period. Price T Rowe Associates Inc. MD bought a new stake in shares of Nukkleus in the 4th quarter valued at $57,000. GM Advisory Group LLC bought a new stake in shares of Nukkleus in the 4th quarter valued at $56,000. Finally, Millennium Management LLC bought a new stake in shares of Nukkleus in the 4th quarter valued at $60,000. 12.47% of the stock is currently owned by institutional investors.

About Nukkleus

Nukkleus Inc, a financial technology company, provides blockchain-enabled technology solutions worldwide. It focuses on providing software and technology solutions for retail foreign exchange trading industry. The company provides transactions platform for dealing and risk management services. It also offers cross-border payment and transactions solutions and blockchain-enabled financial services solutions to institutional investors. In addition, the company provides software, technology, customer sales and marketing, and risk management technology hardware and software solutions.